Le alterazioni elettrocardiografiche espressione di cardiotossicità

Translated title of the contribution: Electrocardiographic changes: Expression of cardiotoxicity

Maria Cristina Lombari, Carlo Gabriele Tocchetti, Carmela Coppola, Angelo Sabato Boccia, Nicola Maurea

Research output: Contribution to journalArticlepeer-review


As the number of drugs and therapeutic strategies for the treatment of cancer continuously increase, early detection and treatment of cardiotoxic side effects are actual and important issue. Along with left ventricular dysfunction, arrhythmic side effects are fairly common. In particular, oncologic patients often present with QT prolongation, since their conditions are associated with concomitant risk factors, such as electrolytic alterations due to dehydration, vomiting or diarrhea, pre-existing cardiovascular diseases, renal or hepathic dysfunctions, other medications which are known for predisposing to QT prolongation.

Translated title of the contributionElectrocardiographic changes: Expression of cardiotoxicity
Original languageItalian
Pages (from-to)55-59
Number of pages5
JournalJournal of Cardiovascular Echography
Issue number2
Publication statusPublished - 2011

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Radiology Nuclear Medicine and imaging


Dive into the research topics of 'Electrocardiographic changes: Expression of cardiotoxicity'. Together they form a unique fingerprint.

Cite this